456. Dalbavancin, a Long-Acting Lipoglycopeptide Antimicrobial Agent, Reduces Length of Stay and Improves Patient Work Productivity in a Hospital Critical Pathway for Acute Bacterial Skin and Skin Structure Infections (ABSSSI)—the ENHANCE ABSSSI Trial

BACKGROUND: Prolonged admissions for acute bacterial skin and skin structure infections (ABSSSI) present an opportunity to improve efficiency and quality of care. A primary reason for admission for ABSSSI is to receive intravenous (IV) antibiotics, where multiple guidelines support shifting care to...

Descripción completa

Detalles Bibliográficos
Autores principales: McCarthy, Matthew W, Keyloun, Katelyn R, Gillard, Patrick, Choi, Justin J, Copp, Ronald, Walsh, Thomas J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809753/
http://dx.doi.org/10.1093/ofid/ofz360.529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809753/
http://dx.doi.org/10.1093/ofid/ofz360.529

Ejemplares similares